SCHEMBL17554365

SCHEMBL17554365

CC(C)(C)OC(=O)N1CCC(Oc2cccc(OCc3ccccc3N)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.48
NEK2 P51955 1/20 0.48
GPR119 Q8TDV5 5/20 0.47
CACNB4 O00305 1/20 0.45
CACNA1A O00555 1/20 0.45
CACNA1G O43497 1/20 0.45
CACNG3 O60359 1/20 0.45
CACNA1F O60840 1/20 0.45
CACNA1H O95180 1/20 0.45
CACNB3 P54284 1/20 0.45
CACNA2D1 P54289 1/20 0.45
CACNG7 P62955 1/20 0.45
CACNA1B Q00975 1/20 0.45
CACNA1D Q01668 1/20 0.45
CACNB1 Q02641 1/20 0.45
CACNG1 Q06432 1/20 0.45
CACNB2 Q08289 1/20 0.45
CACNA1S Q13698 1/20 0.45
CACNA1C Q13936 1/20 0.45
CACNA1E Q15878 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17554458 0.91 GPR119 (0.56) KDM1ANEK2GPR119CACNB4CACNA1A
SCHEMBL30389108 0.91 GPR119 (0.56) KDM1ANEK2GPR119CACNB4CACNA1A
SCHEMBL2195099 0.86 YAP1 (0.55) GPR119CHRM3USP30YAP1
SCHEMBL17560068 0.86 OPRK1 (0.45) KDM1ACHRM3RCOR1
SCHEMBL17560083 0.85 KDM1A (0.49) KDM1AGPR119CHRM3PDE4APDE4B
SCHEMBL30388656 0.85 KDM1A (0.49) KDM1AGPR119CHRM3PDE4APDE4B
SCHEMBL30388671 0.84 GPR119 (0.50) KDM1ANEK2GPR119CACNB4CACNA1A
SCHEMBL17574299 0.84 GPR119 (0.50) KDM1ANEK2GPR119CACNB4CACNA1A
SCHEMBL29796027 0.82 KDM1A (0.58) KDM1AGPR119USP30PDE4APDE4B
SCHEMBL520668 0.82 KDM1A (0.58) KDM1AGPR119USP30PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3189059-B1 THIENOPYRROLES AS HISTONE DEMETHYLASE INHIBITORS ST EUROPEO DI ONCOLOGIA S R L (IT) 2023-02-22 EP disclosed
US-10183952-B2 Thienopyrroles as histone demethylase inhibitors ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2019-01-22 US disclosed
US-20170260197-A1 THIENOPYRROLES AS HISTONE DEMETHYLASE INHIBITORS ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2017-09-14 US disclosed
EP-2993175-A1 Thienopyrroles as histone demethylase inhibitors IEO - Istituto Europeo di Oncologia Srl (IT) 2016-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10183952-B2 Thienopyrroles as histone demethylase inhibitors KDM1A, KDM1B, KDM3A KDM1A 1/4885NEK2 2757/4885GPR119 75/4885
US-20170260197-A1 THIENOPYRROLES AS HISTONE DEMETHYLASE INHIBITORS KDM1A, KDM1B, KDM3A KDM1A 1/4885NEK2 2757/4885GPR119 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.